Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Megan R Haymart"'
Publikováno v:
The Lancet. 401:1531-1544
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c9df2f0fbe3e7801f75c2cc90859a12
https://doi.org/10.1016/s0140-6736(23)00020-x
https://doi.org/10.1016/s0140-6736(23)00020-x
Autor:
Debbie W Chen, Farizah I Rob, Rik Mukherjee, Thomas J Giordano, Megan R Haymart, Mousumi Banerjee
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 107:e4072-e4077
Context Noninvasive encapsulated follicular variant of papillary thyroid cancer was reclassified as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in January 2017. The impact of this nomenclature change at a popu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5247e0e6277d6f982bd5cf6478de25ca
https://doi.org/10.1210/clinem/dgac466
https://doi.org/10.1210/clinem/dgac466
Publikováno v:
Journal of the Endocrine Society. 7
For thyroid cancer clinical trials, the inclusion of participants from diverse patient populations is uniquely important given existing racial/ethnic disparities in thyroid cancer care. Since 2011, a paradigm shift has occurred in the treatment of ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dba0a16315f437eefb580d4965f99bac
https://doi.org/10.1210/jendso/bvad064
https://doi.org/10.1210/jendso/bvad064
Publikováno v:
Endocrine Practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba79831e2d694ed59d2697530081d0a0
https://doi.org/10.1016/j.eprac.2023.05.001
https://doi.org/10.1016/j.eprac.2023.05.001
Autor:
Megan R. Haymart
Publikováno v:
Endocrine Practice. 27:1260-1263
The state of thyroid cancer in 2021 is reviewed including the prevalence of thyroid cancer, vulnerable patient groups such as women and young adults, and known and hypothesized risk factors for thyroid cancer. Understanding the overdiagnosis and over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a9e87d5c5b7c524454d7a461b2bb98
https://doi.org/10.1016/j.eprac.2021.09.006
https://doi.org/10.1016/j.eprac.2021.09.006
Autor:
Nina Jackson Levin, Chiu Yi Tan, Daria Stelmak, Nicholas T. Iannarino, Anao Zhang, Erin Ellman, Lindsey A. Herrel, Emily B. Walling, Molly B. Moravek, Rashmi Chugh, Megan R. Haymart, Brad Zebrack
Publikováno v:
Journal of Adolescent and Young Adult Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20682714f2c30d2aec101c6e87f16c29
https://doi.org/10.1089/jayao.2022.0055
https://doi.org/10.1089/jayao.2022.0055
Autor:
Ann S. Hamilton, Debbie W Chen, Megan R. Haymart, Nina Jackson Levin, David Reyes-Gastelum, Anao Zhang, Bradley Zebrack
Publikováno v:
J Cancer Surviv
PURPOSE: The purpose of this study is to assess change in worry over time in Hispanic women with thyroid cancer. METHODS: Worry about recurrence, quality of life, family at risk, death, and harm from treatments was assessed in 273 Hispanic women with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d160d032936f60b3176193b5ffb751c0
https://doi.org/10.1007/s11764-021-01078-8
https://doi.org/10.1007/s11764-021-01078-8
Autor:
Megan R. Haymart
Publikováno v:
Current opinion in endocrinology, diabetes, and obesity. 29(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5a87dde673f67f93aed2bd40f0279be
https://pubmed.ncbi.nlm.nih.gov/36068936
https://pubmed.ncbi.nlm.nih.gov/36068936
Autor:
Megan R. Haymart, Ann S. Hamilton, Debbie W Chen, David Reyes-Gastelum, Christine M. Veenstra, Mousumi Banerjee
Publikováno v:
Thyroid
Background: Little is known about financial hardship among Hispanic women with thyroid cancer. The goal of this study was to determine the prevalence of financial hardship and to identify correlates of financial hardship in this understudied patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebec745c45deedebd2b50d1f32c3c7e0
https://doi.org/10.1089/thy.2020.0497
https://doi.org/10.1089/thy.2020.0497
Autor:
Josh M. Evron, Scott L. Hummel, David Reyes-Gastelum, Megan R. Haymart, Mousumi Banerjee, Maria Papaleontiou
Publikováno v:
JAMA network open. 5(5)
Cardiovascular disease is the leading cause of death in the United States. Synthetic thyroid hormones are among the 3 most commonly prescribed medications, yet studies evaluating the association between the intensity of thyroid hormone treatment and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e90849ac78c80d4688e8d2455a8d039
https://pubmed.ncbi.nlm.nih.gov/35552725
https://pubmed.ncbi.nlm.nih.gov/35552725